Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Expert Review of Hematology
|
June 2, 2018
Cellular immunotherapy as a therapeutic approach in multiple myeloma
Jessica Liegel, David Avigan, Jacalyn Rosenblatt
American Journal of Hematology
|
July 8, 2015
Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failure
Troy C Lund, Jessica Liegel, Nelli Bejanyan, et al.
Transfusion
|
May 1, 2024
High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality
Zachary M Avigan, Ajoy L Dias, Laura E Dodge, et al.
Cancer Immunology, Immunotherapy : CII
|
July 14, 2022
Personalized tumor vaccine for pancreatic cancer
Shira Orr, Ling Huang, James Moser, et al.
Blood
|
October 7, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia
Marlise R Luskin, Mark A Murakami, Julia Keating, et al.
Science Translational Medicine
|
May 27, 2026
Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma
Adam S Sperling, Benjamin A Derman, Sarah Nikiforow, et al.
British Journal of Haematology
|
March 5, 2019
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
Myrna R Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, et al.
Haematologica
|
February 4, 2021
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model
Dina Stroopinsky, Jessica Liegel, Manoj Bhasin, et al.
Blood
|
March 2, 2023
Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
Anita G Koshy, Haesook T Kim, Jessica Liegel, et al.
Blood Advances
|
August 14, 2025
Vaccine-Educated T cells and a CD123 Bispecific T-Cell Engager for Treatment of Acute Myeloid Leukemia
Jessica Liegel, Dina Stroopinsky, Giulia Cheloni, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Expert Review of Hematology
|
June 2, 2018
Cellular immunotherapy as a therapeutic approach in multiple myeloma
Jessica Liegel, David Avigan, Jacalyn Rosenblatt
American Journal of Hematology
|
July 8, 2015
Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failure
Troy C Lund, Jessica Liegel, Nelli Bejanyan, et al.
Transfusion
|
May 1, 2024
High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality
Zachary M Avigan, Ajoy L Dias, Laura E Dodge, et al.
Cancer Immunology, Immunotherapy : CII
|
July 14, 2022
Personalized tumor vaccine for pancreatic cancer
Shira Orr, Ling Huang, James Moser, et al.
Blood
|
October 7, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia
Marlise R Luskin, Mark A Murakami, Julia Keating, et al.
Science Translational Medicine
|
May 27, 2026
Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma
Adam S Sperling, Benjamin A Derman, Sarah Nikiforow, et al.
British Journal of Haematology
|
March 5, 2019
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
Myrna R Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, et al.
Haematologica
|
February 4, 2021
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model
Dina Stroopinsky, Jessica Liegel, Manoj Bhasin, et al.
Blood
|
March 2, 2023
Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
Anita G Koshy, Haesook T Kim, Jessica Liegel, et al.
Blood Advances
|
August 14, 2025
Vaccine-Educated T cells and a CD123 Bispecific T-Cell Engager for Treatment of Acute Myeloid Leukemia
Jessica Liegel, Dina Stroopinsky, Giulia Cheloni, et al.
Page
of 1